The following table provides an overview of the latest patents of Progenics Pharmaceuticals, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3263571Aug 23, 2023Crystal Form Of (R)-N-Methylnaltrexone Bromide And Uses Thereof1